Ammelburg competitive analysis

Latest publications and patents of Ammelburg New

Explore the latest publications and patents granted to Ammelburg, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Ammelburg against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) PopulationsIONIS PHARMACEUTICALSMay 22, 2024
Products And CompositionsSILENCE THERAPEUTICSJul 31, 2023
Engineered Natural Killer Cells And Uses ThereofONK THERAPEUTICSMar 21, 2023
Biomarkers For Risk Prediction Of MortalityF HOFFMANN LA ROCHESep 12, 2019
Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative DisordersBRUSCHETTINIJun 4, 2019

Latest PTAB cases involving Ammelburg

Discover the latest PTAB cases involving Ammelburg, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ammelburg with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
AMMELBURG5 - - - Highly Aggressive
BRUSCHETTINI11 - - Aggressive
F HOFFMANN LA ROCHE16140 - - Defensive
IONIS PHARMACEUTICALS117 - - Defensive